Efficacy, Safety and Tolerability Study of Agile AG200-15 Transdermal Contraceptive Delivery System
NCT02158572
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
2032
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
AG200-15
Sponsor
Agile Therapeutics